Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
678.00    -7.00 (-1.02%)
Bid:
676.00
Ask:
679.00
Spread: 3.00 (0.444%)
Market Cap: £658.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

EPT Disclosure

11 Jun 2008 11:50

RNS Number : 4674W
Cazenove
11 June 2008
 



DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Cazenove

Company dealt in

Acal Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

5p ordinary

Date of dealing

10th June 2008

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

250

£1.85p

£1.85p

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

3,000

£1.93p

£1.93p

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

11th June 2008

Contact name

Jeffrey Dalton-Brown

Telephone number

0207 155 5017

Name of offeree/offeror with which connected

Acal Plc

Nature of connection (Note 6)

Cazenove are Broker to Acal Plc

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMFKDKQKBKDCAD
Date   Source Headline
10th May 20215:33 pmRNSHolding(s) in Company
20th Apr 20217:00 amRNSFull Year Trading Update
22nd Feb 20215:26 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSAcquisition completion - Limitor GmbH
9th Feb 202112:08 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update
27th Jan 20217:52 amRNSHolding(s) in Company
10th Dec 20208:53 amEQSdiscoverIE Group (DSCV): Another brick in the yellow wall
7th Dec 20204:42 pmRNSHolding(s) in Company
4th Dec 20207:00 amRNSAcquisition of Limitor GmbH
30th Nov 20207:00 amRNSHalf-Year Report
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
23rd Oct 20209:42 amRNSHolding(s) in Company
16th Oct 20201:23 pmRNSHolding(s) in Company
15th Oct 20205:01 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
12th Oct 20209:13 amRNSNOTIFICATION OF MAJOR HOLDINGS
8th Oct 20207:00 amRNSNotice of Trading Update & Half Year Results
26th Aug 20204:03 pmRNSHolding(s) in Company
19th Aug 202012:00 pmRNSResult of AGM
30th Jul 20207:00 amRNSTrading Update
28th Jul 20205:45 pmRNSDirector Declarations
28th Jul 20204:00 pmRNSHolding(s) in Company
27th Jul 202010:00 amRNSHolding(s) in Company
15th Jul 202011:00 amRNSAnnual Report and AGM Notice
14th Jul 202010:00 amRNSHolding(s) in Company
13th Jul 20204:15 pmRNSHolding(s) in Company
13th Jul 20204:00 pmRNSHolding(s) in Company
7th Jul 20209:00 amRNSHolding(s) in Company
3rd Jul 20209:00 amRNSHolding(s) in Company
1st Jul 20205:45 pmRNSDirector LTIP Award
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.